Monday, November 30, 2009

Rheumatoid Arthritis Home>
Rheumatoid Arthritis News>
Actemra helps halt RA progress: study

Font size
- A
- A
- A
Email This

Bookmark

Save

Receive a FREE Osteoarthritis of the knee pamphlet. Start here.

Actemra helps halt RA progress: study

(Reuters) UPDATED 2009-10-17

Results from a new study have found that the rheumatoid arthritis (RA) drug Actemra helps halt the progression of joint damage in people with the condition when combined with the standard treatment of methotrexate. In a study of 1,200 people with RA, scientists found that after two years, 75 percent of subjects who received 4 mg/kg of Actemra and 83 percent of the patients who received 8 mg/kg had no joint damage progression, compared with 66 percent of the patients who took methotrexate alone.
Read full story >

See all Rheumatoid Arthritis News

Font size
- A
- A
- A
Email This
Bookmark

Was this helpful? Yes
Save

Note: All clinical content on this site is physician-reviewed, except material generated by our community members.

Featuring Content From:

By using this service, you accept our Terms of Use. Please read them. The consumer health information on MyRACentral.com is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2005-2009. The HealthCentral Network, Inc. All rights reserved.

We comply with the HONcode standard for trustworthy health information: verify here.